Data

  Data Bridge Market Research analyses that the Autoimmune Disease Diagnosis Market to account USD 8.46 billion by 2029 and growing at a CAGR of 8.15% in the forecast period of 2022-2029. Industry Analysis A single test can’t diagnose most autoimmune diseases. Doctor’s will use a many tests and a review of your symptoms and physical examination to diagnose you. The antinuclear antibody test (ANA) is mostly one of the first tests that doctors use when indications suggest an autoimmune disease. The technical advancement in the field of medical science is the major factor accelerating the growth of the disease diagnosis market. Furthermore, high incidence of autoimmune diseases, increasing awareness about autoimmune diseases are the major factors driving the market of autoimmune disease diagnosis in the forecast period of 2022-2029. The growth in research on autoimmune diseases government initiative and support towards the curb incidents of these disease...